OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $932,000 | -67.5% | 1,658,521 | -0.7% | 0.00% | – |
| Q4 2015 | $2,872,000 | -88.4% | 1,670,350 | -85.8% | 0.00% | -100.0% |
| Q3 2015 | $24,859,000 | -32.4% | 11,780,717 | +58.5% | 0.00% | -25.0% |
| Q2 2015 | $36,792,000 | -5.4% | 7,432,759 | +49.7% | 0.00% | 0.0% |
| Q1 2015 | $38,886,000 | +35.7% | 4,966,182 | +5.0% | 0.00% | +33.3% |
| Q4 2014 | $28,660,000 | +40.4% | 4,729,345 | -1.3% | 0.00% | +50.0% |
| Q3 2014 | $20,409,000 | -20.2% | 4,790,573 | +15.7% | 0.00% | -33.3% |
| Q2 2014 | $25,586,000 | -7.2% | 4,139,892 | -2.3% | 0.00% | 0.0% |
| Q1 2014 | $27,557,000 | -4.7% | 4,238,990 | -18.5% | 0.00% | +50.0% |
| Q4 2013 | $28,918,000 | +12.0% | 5,201,866 | +23.7% | 0.00% | -33.3% |
| Q3 2013 | $25,828,000 | +29.8% | 4,206,765 | +23.7% | 0.00% | 0.0% |
| Q2 2013 | $19,895,000 | – | 3,401,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |